Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology
Старческая астения и рак: значение для онкологической хирургии, медицинской онкологии и радиационной онкологии
2017-07-21
SCID: 54.1/2a6urxsb
Discuss with AI
chemotherapy intolerancefrailtymedical oncologyoncology surgeryradiation oncology
Figures from the paper
Abstract (AI)
Answer questions and earn CME/CNE The concept of frailty has become increasingly recognized as one of the most important issues in health care and health outcomes and is of particular importance in patients with cancer who are receiving treatment with surgery, chemotherapy, and radiotherapy. Because both cancer itself, as well as the therapies offered, can be significant additional stressors that challenge a patient's physiologic reserve, the incidence of frailty in older patients with cancer is especially high-it is estimated that over one-half of older patients with cancer have frailty or prefrailty. Defining frailty can be challenging, however. Put simply, frailty is a state of extreme vulnerability to stressors that leads to adverse health outcomes. In reality, frailty is a complex, multidimensional, and cyclical state of diminished physiologic reserve that results in decreased resiliency and adaptive capacity and increased vulnerability to stressors. In addition, over 70 different measures of frailty have been proposed. Still, it has been demonstrated that frail patients are at increased risk of postoperative complications, chemotherapy intolerance, disease progression, and death. Although international standardization of frailty cutoff points are needed, continued efforts by oncology physicians and surgeons to identify frailty and promote multidisciplinary decision making will help to develop more individualized management strategies and optimize care for patients with cancer. CA Cancer J Clin 2017;67:362-377. © 2017 American Cancer Society.
Key Findings
1
Although more than 70 frailty measures exist and international cutoff standardization is needed, identifying frailty and using multidisciplinary decision-making can support individualized cancer care.
2
Cancer treatments—including surgery, chemotherapy, and radiotherapy—can further stress physiologic reserve in already vulnerable patients.
3
Frailty is a multidimensional state of diminished physiologic reserve that increases vulnerability to stressors and adverse health outcomes.
4
Frailty is associated with increased risks of postoperative complications, chemotherapy intolerance, disease progression, and mortality.
5
More than one-half of older patients with cancer are estimated to have frailty or prefrailty, reflecting particularly high vulnerability during treatment.
Research Object
older patients with cancer receiving surgery, chemotherapy, or radiotherapy
Research Subject
frailty and its associations with treatment tolerance, postoperative complications, disease progression, mortality, and individualized oncology management
Publication Details
Publication Date
2017-07-21
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest